Coexistence of neuronal intranuclear inclusion disease and amyotrophic lateral sclerosis: an autopsy case.
Amyotrophic lateral sclerosis
Autopsy
Case report
Magnetic resonance imaging
Neuronal intranuclear inclusion disease
Paravermal lesion
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
09 Jul 2021
09 Jul 2021
Historique:
received:
08
03
2021
accepted:
29
06
2021
entrez:
10
7
2021
pubmed:
11
7
2021
medline:
20
7
2021
Statut:
epublish
Résumé
Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disease. Pathologically, it is characterized by eosinophilic hyaline intranuclear inclusions in the cells of the visceral organs as well as central, peripheral, and autonomic nervous system cells. Recently, a GGC repeat expansion in the NOTCH2NLC gene has been identified as the etiopathological agent of NIID. Interestingly, this GGC repeat expansion was also reported in some patients with a clinical diagnosis of amyotrophic lateral sclerosis (ALS). However, there are no autopsy-confirmed cases of concurrent NIID and ALS. A 60-year-old Taiwanese woman reported a four-month history of progressive weakness beginning in the right foot that spread to all four extremities. She was diagnosed with ALS because she met the revised El Escorial diagnostic criteria for definite ALS with upper and lower motor neuron involvement in the cervical, thoracic, and lumbosacral regions. She died of respiratory failure at 22 months from ALS onset, at the age of 62 years. Brain magnetic resonance imaging (MRI) revealed lesions in the medial part of the cerebellar hemisphere, right beside the vermis (paravermal lesions). The subclinical neuropathy, indicated by a nerve conduction study (NCS), prompted a potential diagnosis of NIID. Antemortem skin biopsy and autopsy confirmed the coexistence of pathology consistent with both ALS and NIID. We observed neither eccentric distribution of p62-positive intranuclear inclusions in the areas with abundant large motor neurons nor cytopathological coexistence of ALS and NIID pathology in motor neurons. This finding suggested that ALS and NIID developed independently in this patient. We describe a case of concurrent NIID and ALS discovered during an autopsy. Abnormal brain MRI findings, including paravermal lesions, could indicate the coexistence of NIID even in patients with ALS showing characteristic clinical phenotypes.
Sections du résumé
BACKGROUND
BACKGROUND
Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disease. Pathologically, it is characterized by eosinophilic hyaline intranuclear inclusions in the cells of the visceral organs as well as central, peripheral, and autonomic nervous system cells. Recently, a GGC repeat expansion in the NOTCH2NLC gene has been identified as the etiopathological agent of NIID. Interestingly, this GGC repeat expansion was also reported in some patients with a clinical diagnosis of amyotrophic lateral sclerosis (ALS). However, there are no autopsy-confirmed cases of concurrent NIID and ALS.
CASE PRESENTATION
METHODS
A 60-year-old Taiwanese woman reported a four-month history of progressive weakness beginning in the right foot that spread to all four extremities. She was diagnosed with ALS because she met the revised El Escorial diagnostic criteria for definite ALS with upper and lower motor neuron involvement in the cervical, thoracic, and lumbosacral regions. She died of respiratory failure at 22 months from ALS onset, at the age of 62 years. Brain magnetic resonance imaging (MRI) revealed lesions in the medial part of the cerebellar hemisphere, right beside the vermis (paravermal lesions). The subclinical neuropathy, indicated by a nerve conduction study (NCS), prompted a potential diagnosis of NIID. Antemortem skin biopsy and autopsy confirmed the coexistence of pathology consistent with both ALS and NIID. We observed neither eccentric distribution of p62-positive intranuclear inclusions in the areas with abundant large motor neurons nor cytopathological coexistence of ALS and NIID pathology in motor neurons. This finding suggested that ALS and NIID developed independently in this patient.
CONCLUSIONS
CONCLUSIONS
We describe a case of concurrent NIID and ALS discovered during an autopsy. Abnormal brain MRI findings, including paravermal lesions, could indicate the coexistence of NIID even in patients with ALS showing characteristic clinical phenotypes.
Identifiants
pubmed: 34243731
doi: 10.1186/s12883-021-02306-5
pii: 10.1186/s12883-021-02306-5
pmc: PMC8268606
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
273Informations de copyright
© 2021. The Author(s).
Références
Ann Neurol. 2019 Dec;86(6):962-968
pubmed: 31433517
Heliyon. 2020 Aug 11;6(8):e04675
pubmed: 32817896
Muscle Nerve. 2000 Mar;23(3):344-52
pubmed: 10679710
Neurology. 2011 Apr 19;76(16):1372-6
pubmed: 21411744
Nat Genet. 2019 Aug;51(8):1215-1221
pubmed: 31332381
Neurol Clin. 2015 Nov;33(4):855-76
pubmed: 26515626
Brain. 2016 Dec;139(Pt 12):3170-3186
pubmed: 27797808
Neurology. 2007 Dec 11;69(24):2236-42
pubmed: 18071143
Brain. 2019 Jan 1;143(1):222-233
pubmed: 31819945
AJNR Am J Neuroradiol. 2018 Sep;39(9):E100-E101
pubmed: 30072371
Neurology. 2020 Dec 15;95(24):e3394-e3405
pubmed: 32989102
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):354-6
pubmed: 24039026
Amyotroph Lateral Scler. 2012 Jan;13(1):74-83
pubmed: 21861592
Brain. 2017 Aug 1;140(8):e52
pubmed: 28899012
J Neurol. 1999 Jun;246(6):438-42
pubmed: 10431767
J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):746-9
pubmed: 17575020
Nat Genet. 2019 Aug;51(8):1222-1232
pubmed: 31332380
Neuropathology. 2003 Dec;23(4):351-9
pubmed: 14719553
Am J Hum Genet. 2019 Jul 3;105(1):166-176
pubmed: 31178126
Neurology. 2005 Nov 22;65(10):1538-43
pubmed: 16301479
Brain. 2006 Jan;129(Pt 1):243-55
pubmed: 16332642
AJNR Am J Neuroradiol. 2017 Nov;38(11):2100-2104
pubmed: 28818825
Brain. 2017 Aug 1;140(8):e51
pubmed: 28899011